5 amino 1mq with nad+ METABOLIC BLEND (NAD+ + MOTS-C + 5-Amino-1MQ) 100/10/10mg NAD+ / MOTS-c / 5-Amino-1MQ

Injection Site : Different sites may require different needle lengths and gauges to promote the correct and comfortable delivery of the medication

The FDA's Pharmacy Compounding Advisory Committee reviewed AOD-9604 in December 2024 and recommended against permitting its use in 503A pharmacy compounding

Food and Drug Administration (FDA) for the uses described on this website

By inhibiting NNMT, 5-Amino-1MQ may spare nicotinamide for NAD+ synthesis, thereby activating SIRT1 (Sirtuin 1) pathways associated with mitochondrial biogenesis and fat oxidation [3]

Folic acid alone will not treat Vitamin B12 deficiency or prevent possible damage to the spinal cord